Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women
NCT ID: NCT04095442
Last Updated: 2024-03-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2019-11-01
2023-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Beetroot Juice Supplementation Dose on Neuromuscular Performance During Resistance Exercise
NCT05957835
Beetroot Juice Effects on Contractile or Neuromuscular Properties in Male Trained Sprinters
NCT06675682
Beetroot Juice Doses and Anaerobic Performance
NCT02919254
Acute Effects of Beetroot Juice on Isometric Knee Extension Strength, Explosive Strength and Local Muscular Endurance
NCT05567926
Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance
NCT06596395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During an initial visit, subjects will complete the informed consent process, be instructed on the requirements of the study, and practice the exercise protocol (see below).
Study Visit Two:
Subjects will be tested after they have avoided exercise, caffeine, alcohol, chewing gum, and foods high in nitrate (e.g., spinach, beets, collard greens) for at least 24 hours. They will also be asked to not use any mouthwash products during this period. They will then provide provide a saliva sample for subsequent measurement of nitrate and nitrite concentrations and have their breath nitric oxide levels measured using a portable analyzer. The maximal knee extensor speed and power of their knee extensor muscles will then be measured using an isokinetic dynamometer. This machine can control the speed of movement while measuring the maximal force (torque) that a subject can voluntarily produce.
Subjects will then be randomly assigned to receive either an antibacterial mouthwash (Cepacol©, Reckitt Benckiser, Parsippany, NJ) or, as a control solution, an alcohol-free "natural" mouthwash (Tom's of Maine©, Kennebunk, ME). Participants will be asked to rinse their mouth as directed on the product's packaging for 30 s twice per day for 7 (+/-2) days and to record the usage of the mouthwash on a provided form. Subjects will then return for Study Visit 3 (see below). This is considered a single-blind study, which means that the investigators will not know what type of mouthwash a subject is receives.
Study Visit Three:
At the end of the treatment period, subjects will be asked to return to undergo the same procedures as described for Study Visit Two.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cepacol
Cepacol
Twice-daily use of Cepacol per the manufacturer's guidelines
Tom's Natural Mouthwash
Tom's Natural Mouthwash
Twice-daily use of Tom's Natural Mouthwash per the manufacturer's guidelines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cepacol
Twice-daily use of Cepacol per the manufacturer's guidelines
Tom's Natural Mouthwash
Twice-daily use of Tom's Natural Mouthwash per the manufacturer's guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No current use of mouthwash
Exclusion:
* Men and Women \<18 or 30\> y of age
* Unable to provide informed consent
* Current users of mouthwash
* Current antibiotic use
* Current smokers
* Currently pregnant or lactating
* Stage II hypertension (resting blood pressure \>140/\>90)
An answer of yes to any of the seven questions on the first page of the Physical Activity Readiness Questionnaire (PAR-Q) indicating that the subject is not physically ready for exercise without a medical exam. These exclusions include the following:
* If participant's doctor has ever said that he/she has a heart condition and that he/she should only do physical activity recommended by a doctor
* Pain in chest when doing physical activity
* In past month, chest pain when not doing physical activity
* If participant has ever lost balance because of dizziness or has ever lost consciousness
* Bone or joint problem that could be made worse by change in physical activity
* Currently on prescribed drugs for blood pressure or heart condition.
* If the participant knows of any other reason why he/she should not do physical activity.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Coggan
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University School of Health and Human Sciences
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1907204336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.